Showing 1 - 3 results of 3 for search 'Deus Mwesigwa', query time: 0.04s Refine Results
  1. 1
    Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda

    Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda by Gerald Kevin Oluka, Gerald Kevin Oluka, Patricia Namubiru, Laban Kato, Violet Ankunda, Ben Gombe, Matthew Cotten, Matthew Cotten, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, Julie Fox, Jennifer Serwanga, Jennifer Serwanga, Claire Baine, Jackson Sembera, Susan Mugaba, Christine Hermilia Akoli, Geoffrey Odoch, Deus Mwesigwa, Peter Ejou, Joseph Ssebwana Katende

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

    Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy by Jennifer Serwanga, Jennifer Serwanga, Claire Baine, Susan Mugaba, Violet Ankunda, Betty Oliver Auma, Gerald Kevin Oluka, Gerald Kevin Oluka, Laban Kato, Isaac Kitabye, Jackson Sembera, Geoffrey Odoch, Peter Ejou, Amina Nalumansi, Ben Gombe, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, the COVID-19 Immunoprofiling Team, the COVID-19 Immunoprofiling Team, Christine Hermilia Akoli, Deus Mwesigwa, Ivan Ssali, Hellen Nantambi, Angela Namuyanja, Solomon Opio, Arthur Watelo Kalyebi, Joseph Ssebwana Katende

    Published 2023-05-01
    Get full text
    Article
  3. 3
    Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months

    Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months by Jennifer Serwanga, Jennifer Serwanga, Violet Ankunda, Jackson Sembera, Laban Kato, Gerald Kevin Oluka, Gerald Kevin Oluka, Claire Baine, Geoffrey Odoch, John Kayiwa, Betty Oliver Auma, Mark Jjuuko, Christopher Nsereko, Matthew Cotten, Matthew Cotten, Nathan Onyachi, Moses Muwanga, Tom Lutalo, Julie Fox, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Patricia Namubiru, Hermilia Christine Akoli, Susan Mugaba, Amina Nalumansi, Geoffrey Odoch, Kibengo Freddie, Deus Mwesigwa, Joseph Ssebwana Katende

    Published 2023-03-01
    Get full text
    Article

Search Tools: